| Literature DB >> 12180477 |
Jyoti Wadhwa1, Lalit Kumar, Vinod Kochupillai.
Abstract
In patients with multiple myeloma, a good complete response rate and disease-free survival may be achieved with sequential chemotherapy using VAD and VMCP, which is an alternative effective and less expensive treatment regimen. This regimen thus assumes particular significance in developing nations like India, where the majority of patients with myeloma cannot afford the cost of high-dose chemotherapy with stem cell rescue.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12180477 DOI: 10.1385/MO:19:2:105
Source DB: PubMed Journal: Med Oncol ISSN: 1357-0560 Impact factor: 3.064